Project acronym Antibodyomics
Project Vaccine profiling and immunodiagnostic discovery by high-throughput antibody repertoire analysis
Researcher (PI) Sai Tota Reddy
Host Institution (HI) EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
Call Details Starting Grant (StG), LS7, ERC-2015-STG
Summary Vaccines and immunodiagnostics have been vital for public health and medicine, however a quantitative molecular understanding of vaccine-induced antibody responses is lacking. Antibody research is currently going through a big-data driven revolution, largely due to progress in next-generation sequencing (NGS) and bioinformatic analysis of antibody repertoires. A main advantage of high-throughput antibody repertoire analysis is that it provides a wealth of quantitative information not possible with other classical methods of antibody analysis (i.e., serum titers); this information includes: clonal distribution and diversity, somatic hypermutation patterns, and lineage tracing. In preliminary work my group has established standardized methods for antibody repertoire NGS, including an experimental-bioinformatic pipeline for error and bias correction that enables highly accurate repertoire sequencing and analysis. The overall goal of this proposal will be to apply high-throughput antibody repertoire analysis for quantitative vaccine profiling and discovery of next-generation immunodiagnostics. Using mouse subunit vaccination as our model system, we will answer for the first time, a fundamental biological question within the context of antibody responses - what is the link between genotype (antibody repertoire) and phenotype (serum antibodies)? We will expand upon this approach for improved rational vaccine design by quantitatively determining the impact of a comprehensive set of subunit vaccination parameters on complete antibody landscapes. Finally, we will develop advanced bioinformatic methods to discover immunodiagnostics based on antibody repertoire sequences. In summary, this proposal lays the foundation for fundamentally new approaches in the quantitative analysis of antibody responses, which long-term will promote the development of next-generation vaccines and immunodiagnostics.
Summary
Vaccines and immunodiagnostics have been vital for public health and medicine, however a quantitative molecular understanding of vaccine-induced antibody responses is lacking. Antibody research is currently going through a big-data driven revolution, largely due to progress in next-generation sequencing (NGS) and bioinformatic analysis of antibody repertoires. A main advantage of high-throughput antibody repertoire analysis is that it provides a wealth of quantitative information not possible with other classical methods of antibody analysis (i.e., serum titers); this information includes: clonal distribution and diversity, somatic hypermutation patterns, and lineage tracing. In preliminary work my group has established standardized methods for antibody repertoire NGS, including an experimental-bioinformatic pipeline for error and bias correction that enables highly accurate repertoire sequencing and analysis. The overall goal of this proposal will be to apply high-throughput antibody repertoire analysis for quantitative vaccine profiling and discovery of next-generation immunodiagnostics. Using mouse subunit vaccination as our model system, we will answer for the first time, a fundamental biological question within the context of antibody responses - what is the link between genotype (antibody repertoire) and phenotype (serum antibodies)? We will expand upon this approach for improved rational vaccine design by quantitatively determining the impact of a comprehensive set of subunit vaccination parameters on complete antibody landscapes. Finally, we will develop advanced bioinformatic methods to discover immunodiagnostics based on antibody repertoire sequences. In summary, this proposal lays the foundation for fundamentally new approaches in the quantitative analysis of antibody responses, which long-term will promote the development of next-generation vaccines and immunodiagnostics.
Max ERC Funding
1 492 586 €
Duration
Start date: 2016-06-01, End date: 2021-05-31
Project acronym APACHE
Project Atmospheric Pressure plAsma meets biomaterials for bone Cancer HEaling
Researcher (PI) Cristina CANAL BARNILS
Host Institution (HI) UNIVERSITAT POLITECNICA DE CATALUNYA
Call Details Starting Grant (StG), PE8, ERC-2016-STG
Summary Cold atmospheric pressure plasmas (APP) have been reported to selectively kill cancer cells without damaging the surrounding tissues. Studies have been conducted on a variety of cancer types but to the best of our knowledge not on any kind of bone cancer. Treatment options for bone cancer include surgery, chemotherapy, etc. and may involve the use of bone grafting biomaterials to replace the surgically removed bone.
APACHE brings a totally different and ground-breaking approach in the design of a novel therapy for bone cancer by taking advantage of the active species generated by APP in combination with biomaterials to deliver the active species locally in the diseased site. The feasibility of this approach is rooted in the evidence that the cellular effects of APP appear to strongly involve the suite of reactive species created by plasmas, which can be derived from a) direct treatment of the malignant cells by APP or b) indirect treatment of the liquid media by APP which is then put in contact with the cancer cells.
In APACHE we aim to investigate the fundamentals involved in the lethal effects of cold plasmas on bone cancer cells, and to develop improved bone cancer therapies. To achieve this we will take advantage of the highly reactive species generated by APP in the liquid media, which we will use in an incremental strategy: i) to investigate the effects of APP treated liquid on bone cancer cells, ii) to evaluate the potential of combining APP treated liquid in a hydrogel vehicle with/wo CaP biomaterials and iii) to ascertain the potential three directional interactions between APP reactive species in liquid medium with biomaterials and with chemotherapeutic drugs.
The methodological approach will involve an interdisciplinary team, dealing with plasma diagnostics in gas and liquid media; with cell biology and the effects of APP treated with bone tumor cells and its combination with biomaterials and/or with anticancer drugs.
Summary
Cold atmospheric pressure plasmas (APP) have been reported to selectively kill cancer cells without damaging the surrounding tissues. Studies have been conducted on a variety of cancer types but to the best of our knowledge not on any kind of bone cancer. Treatment options for bone cancer include surgery, chemotherapy, etc. and may involve the use of bone grafting biomaterials to replace the surgically removed bone.
APACHE brings a totally different and ground-breaking approach in the design of a novel therapy for bone cancer by taking advantage of the active species generated by APP in combination with biomaterials to deliver the active species locally in the diseased site. The feasibility of this approach is rooted in the evidence that the cellular effects of APP appear to strongly involve the suite of reactive species created by plasmas, which can be derived from a) direct treatment of the malignant cells by APP or b) indirect treatment of the liquid media by APP which is then put in contact with the cancer cells.
In APACHE we aim to investigate the fundamentals involved in the lethal effects of cold plasmas on bone cancer cells, and to develop improved bone cancer therapies. To achieve this we will take advantage of the highly reactive species generated by APP in the liquid media, which we will use in an incremental strategy: i) to investigate the effects of APP treated liquid on bone cancer cells, ii) to evaluate the potential of combining APP treated liquid in a hydrogel vehicle with/wo CaP biomaterials and iii) to ascertain the potential three directional interactions between APP reactive species in liquid medium with biomaterials and with chemotherapeutic drugs.
The methodological approach will involve an interdisciplinary team, dealing with plasma diagnostics in gas and liquid media; with cell biology and the effects of APP treated with bone tumor cells and its combination with biomaterials and/or with anticancer drugs.
Max ERC Funding
1 499 887 €
Duration
Start date: 2017-04-01, End date: 2022-03-31
Project acronym BATMAN
Project Development of Quantitative Metrologies to Guide Lithium Ion Battery Manufacturing
Researcher (PI) Vanessa Wood
Host Institution (HI) EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
Call Details Starting Grant (StG), PE8, ERC-2015-STG
Summary Lithium ion batteries offer tremendous potential as an enabling technology for sustainable transportation and development. However, their widespread usage as the energy storage solution for electric mobility and grid-level integration of renewables is impeded by the fact that current state-of-the-art lithium ion batteries have energy densities that are too small, charge- and discharge rates that are too low, and costs that are too high. Highly publicized instances of catastrophic failure of lithium ion batteries raise questions of safety. Understanding the limitations to battery performance and origins of the degradation and failure is highly complex due to the difficulties in studying interrelated processes that take place at different length and time scales in a corrosive environment. In the project, we will (1) develop and implement quantitative methods to study the complex interrelations between structure and electrochemistry occurring at the nano-, micron-, and milli-scales in lithium ion battery active materials and electrodes, (2) conduct systematic experimental studies with our new techniques to understand the origins of performance limitations and to develop design guidelines for achieving high performance and safe batteries, and (3) investigate economically viable engineering solutions based on these guidelines to achieve high performance and safe lithium ion batteries.
Summary
Lithium ion batteries offer tremendous potential as an enabling technology for sustainable transportation and development. However, their widespread usage as the energy storage solution for electric mobility and grid-level integration of renewables is impeded by the fact that current state-of-the-art lithium ion batteries have energy densities that are too small, charge- and discharge rates that are too low, and costs that are too high. Highly publicized instances of catastrophic failure of lithium ion batteries raise questions of safety. Understanding the limitations to battery performance and origins of the degradation and failure is highly complex due to the difficulties in studying interrelated processes that take place at different length and time scales in a corrosive environment. In the project, we will (1) develop and implement quantitative methods to study the complex interrelations between structure and electrochemistry occurring at the nano-, micron-, and milli-scales in lithium ion battery active materials and electrodes, (2) conduct systematic experimental studies with our new techniques to understand the origins of performance limitations and to develop design guidelines for achieving high performance and safe batteries, and (3) investigate economically viable engineering solutions based on these guidelines to achieve high performance and safe lithium ion batteries.
Max ERC Funding
1 500 000 €
Duration
Start date: 2016-05-01, End date: 2021-04-30
Project acronym BioProbe
Project "VERTICAL MICROFLUIDIC PROBE: A nanoliter ""Swiss army knife"" for chemistry and physics at biological interfaces"
Researcher (PI) Govindkrishna Govind Kaigala
Host Institution (HI) IBM RESEARCH GMBH
Call Details Starting Grant (StG), LS7, ERC-2012-StG_20111109
Summary Life is fundamentally characterised by order, compartmentalisation and biochemical reactions, which occurs at the right place right time – within, on the surface and between cells. Only a proportion of life processes can be addressed with contemporary approaches like liquid encapsulations (e.g. droplets) or engineering compartments (e.g. scaffolds). I believe these approaches are severely limited. I am convinced that a technique to study, work and locally probe adherent cells & tissues at micrometer distances from cell surfaces in “open space” would represent a major advance for the biology of biointerfaces. I therefore propose a non-contact, scanning technology, which spatially confines nanoliter volumes of chemicals for interacting with cells at the µm-length scale. This technology called the vertical microfluidic probe (vMFP) – that I developed at IBM-Zurich – shapes liquid on surfaces hydrodynamically and is compatible with samples on Petri dishes & microtiter plates. The project is organized in 4 themes:
(1) Advancing the vMFP by understanding the interaction of liquid flows with biointerfaces, integrating functional elements (e.g. heaters/electrodes, cell traps) & precision control.
(2) Developing a higher resolution method to stain tissue sections for multiple markers & better quality information.
(3) Retrieving rare elements such as circulating tumor cells from biologically diverse libraries.
(4) Patterning cells for applications in regenerative medicine.
Since cells & tissues will no longer be limited by closed systems, the vMFP will enable a completely new range of experiments to be performed in a highly interactive, versatile & precise manner – this approach departs from classical “closed” microfluidics. It is very likely that such a tool by providing multifunctional capabilities akin to the proverbial ‘Swiss army knife’ will be a unique facilitator for investigations of previously unapproachable problems in cell biology & the life science.
Summary
Life is fundamentally characterised by order, compartmentalisation and biochemical reactions, which occurs at the right place right time – within, on the surface and between cells. Only a proportion of life processes can be addressed with contemporary approaches like liquid encapsulations (e.g. droplets) or engineering compartments (e.g. scaffolds). I believe these approaches are severely limited. I am convinced that a technique to study, work and locally probe adherent cells & tissues at micrometer distances from cell surfaces in “open space” would represent a major advance for the biology of biointerfaces. I therefore propose a non-contact, scanning technology, which spatially confines nanoliter volumes of chemicals for interacting with cells at the µm-length scale. This technology called the vertical microfluidic probe (vMFP) – that I developed at IBM-Zurich – shapes liquid on surfaces hydrodynamically and is compatible with samples on Petri dishes & microtiter plates. The project is organized in 4 themes:
(1) Advancing the vMFP by understanding the interaction of liquid flows with biointerfaces, integrating functional elements (e.g. heaters/electrodes, cell traps) & precision control.
(2) Developing a higher resolution method to stain tissue sections for multiple markers & better quality information.
(3) Retrieving rare elements such as circulating tumor cells from biologically diverse libraries.
(4) Patterning cells for applications in regenerative medicine.
Since cells & tissues will no longer be limited by closed systems, the vMFP will enable a completely new range of experiments to be performed in a highly interactive, versatile & precise manner – this approach departs from classical “closed” microfluidics. It is very likely that such a tool by providing multifunctional capabilities akin to the proverbial ‘Swiss army knife’ will be a unique facilitator for investigations of previously unapproachable problems in cell biology & the life science.
Max ERC Funding
1 488 600 €
Duration
Start date: 2013-01-01, End date: 2017-12-31
Project acronym CAMBAT
Project Calcium and magnesium metal anode based batteries
Researcher (PI) Alexandre PONROUCH
Host Institution (HI) AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS
Call Details Starting Grant (StG), PE8, ERC-2016-STG
Summary Li-ion battery is ubiquitous and has emerged as the major contender to power electric vehicles, yet Li-ion is slowly but surely reaching its limits and controversial debates on lithium supply cannot be ignored. New sustainable battery chemistries must be developed and the most appealing alternatives are to use Ca or Mg metal anodes which would bring a breakthrough in terms of energy density relying on much more abundant elements. Since Mg and Ca do not appear to be plagued by dendrite formation like Li, metal anodes could thus safely be used. While standard electrolytes forming stable passivation layers at the electrode/electrolyte interfaces enabled the success of the Li-ion technology, the migration of divalent cations through a passivation layer was thought to be impossible. Thus, all research efforts to date have been devoted to the formulation of electrolytes that do not form such layer. This approach comes with complex electrolyte, highly corrosive and with narrow electrochemical stability window leading to incompatibility with high voltage cathodes thus penalizing energy density.
The applicant demonstrated that calcium can be reversibly plated and stripped through a stable passivation layer when transport properties within the electrolyte are tuned (decreasing ion pair formation). CAMBAT aims at developing new electrolytes forming stable passivation layers and allowing the migration of Ca2+ and Mg2+. Such a dramatic shift in the methodology would allow considering a completely new family of electrolytes enabling the evaluation of high voltage cathode materials that cannot be tested in the electrolytes available nowadays. 1Ah prototype cells will be assembled as proof of concept, targets for energy density and cost being ca. 300 Wh/kg and 250 $/kWh, respectively, thus doubling the energy density while dividing by at least a factor of 2 the price when compared to state of the art Li-ion batteries and having the potential for being SAFER (absence of dendrite).
Summary
Li-ion battery is ubiquitous and has emerged as the major contender to power electric vehicles, yet Li-ion is slowly but surely reaching its limits and controversial debates on lithium supply cannot be ignored. New sustainable battery chemistries must be developed and the most appealing alternatives are to use Ca or Mg metal anodes which would bring a breakthrough in terms of energy density relying on much more abundant elements. Since Mg and Ca do not appear to be plagued by dendrite formation like Li, metal anodes could thus safely be used. While standard electrolytes forming stable passivation layers at the electrode/electrolyte interfaces enabled the success of the Li-ion technology, the migration of divalent cations through a passivation layer was thought to be impossible. Thus, all research efforts to date have been devoted to the formulation of electrolytes that do not form such layer. This approach comes with complex electrolyte, highly corrosive and with narrow electrochemical stability window leading to incompatibility with high voltage cathodes thus penalizing energy density.
The applicant demonstrated that calcium can be reversibly plated and stripped through a stable passivation layer when transport properties within the electrolyte are tuned (decreasing ion pair formation). CAMBAT aims at developing new electrolytes forming stable passivation layers and allowing the migration of Ca2+ and Mg2+. Such a dramatic shift in the methodology would allow considering a completely new family of electrolytes enabling the evaluation of high voltage cathode materials that cannot be tested in the electrolytes available nowadays. 1Ah prototype cells will be assembled as proof of concept, targets for energy density and cost being ca. 300 Wh/kg and 250 $/kWh, respectively, thus doubling the energy density while dividing by at least a factor of 2 the price when compared to state of the art Li-ion batteries and having the potential for being SAFER (absence of dendrite).
Max ERC Funding
1 688 705 €
Duration
Start date: 2017-01-01, End date: 2021-12-31
Project acronym CATACOAT
Project Nanostructured catalyst overcoats for renewable chemical production from biomass
Researcher (PI) Jeremy Scott LUTERBACHER
Host Institution (HI) ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Call Details Starting Grant (StG), PE8, ERC-2017-STG
Summary In the CATACOAT project, we will develop layer-by-layer solution-processed catalyst overcoating methods, which will result in catalysts that have both targeted and broad impacts. We will produce highly active, stable and selective catalysts for the upgrading of lignin – the largest natural source of aromatic chemicals – into commodity chemicals, which will have an important targeted impact. The broader impact of our work will lie in the production of catalytic materials with unprecedented control over the active site architecture.
There is an urgent need to provide these cheap, stable, selective, and highly active catalysts for renewable molecule production. Thanks to its availability and relatively low cost, lignocellulosic biomass is an attractive source of renewable carbon. However, unlike petroleum, biomass-derived molecules are highly oxygenated, and often produced in dilute-aqueous streams. Heterogeneous catalysts – the workhorses of the petrochemical industry – are sensitive to water and contain many metals that easily sinter and leach in liquid-phase conditions. The production of renewable chemicals from biomass, especially valuable aromatics, often requires expensive platinum group metals and suffers from low selectivity.
Catalyst overcoating presents a potential solution to this problem. Recent breakthroughs using catalyst overcoating with atomic layer deposition (ALD) showed that base metal catalysts can be stabilized against sintering and leaching in liquid phase conditions. However, ALD creates dramatic drops in activity due to excessive coverage, and forms an overcoat that cannot be tuned.
Our materials will feature the controlled placement of metal sites (including single atoms), several oxide sites, and even molecular imprints with sub-nanometer precision within highly accessible nanocavities. We anticipate that such materials will create unprecedented opportunities for reducing cost and increasing sustainability in the chemical industry and beyond.
Summary
In the CATACOAT project, we will develop layer-by-layer solution-processed catalyst overcoating methods, which will result in catalysts that have both targeted and broad impacts. We will produce highly active, stable and selective catalysts for the upgrading of lignin – the largest natural source of aromatic chemicals – into commodity chemicals, which will have an important targeted impact. The broader impact of our work will lie in the production of catalytic materials with unprecedented control over the active site architecture.
There is an urgent need to provide these cheap, stable, selective, and highly active catalysts for renewable molecule production. Thanks to its availability and relatively low cost, lignocellulosic biomass is an attractive source of renewable carbon. However, unlike petroleum, biomass-derived molecules are highly oxygenated, and often produced in dilute-aqueous streams. Heterogeneous catalysts – the workhorses of the petrochemical industry – are sensitive to water and contain many metals that easily sinter and leach in liquid-phase conditions. The production of renewable chemicals from biomass, especially valuable aromatics, often requires expensive platinum group metals and suffers from low selectivity.
Catalyst overcoating presents a potential solution to this problem. Recent breakthroughs using catalyst overcoating with atomic layer deposition (ALD) showed that base metal catalysts can be stabilized against sintering and leaching in liquid phase conditions. However, ALD creates dramatic drops in activity due to excessive coverage, and forms an overcoat that cannot be tuned.
Our materials will feature the controlled placement of metal sites (including single atoms), several oxide sites, and even molecular imprints with sub-nanometer precision within highly accessible nanocavities. We anticipate that such materials will create unprecedented opportunities for reducing cost and increasing sustainability in the chemical industry and beyond.
Max ERC Funding
1 785 195 €
Duration
Start date: 2017-12-01, End date: 2022-11-30
Project acronym CEMOS
Project Crystal Engineering for Molecular Organic Semiconductors
Researcher (PI) Kevin Sivula
Host Institution (HI) ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Call Details Starting Grant (StG), PE8, ERC-2013-StG
Summary "The urgent need to develop inexpensive and ubiquitous solar energy conversion cannot be overstated. Solution processed organic semiconductors can enable this goal as they support drastically less expensive fabrication techniques compared to traditional semiconductors. Molecular organic semiconductors (MOSs) offer many advantages to their more-common pi-conjugated polymer counterparts, however a clear and fundamental challenge to enable the goal of high performance solution-processable molecular organic semiconductor devices is to develop the ability to control the crystal packing, crystalline domain size, and mixing ability (for multicomponent blends) in the thin-film device geometry. The CEMOS project will accomplish this by pioneering innovative methods of “bottom-up” crystal engineering for organic semiconductors. We will employ specifically tailored molecules designed to leverage both thermodynamic and kinetic aspects of molecular organic semiconductor systems to direct and control crystalline packing, promote crystallite nucleation, compatibilize disparate phases, and plasticize inelastic materials. We will demonstrate that our new classes of materials can enable the tuning of the charge carrier transport and morphology in MOS thin films, and we will evaluate their performance in actual thin-film transistor (TFT) and organic photovoltaic (OPV) devices. Our highly interdisciplinary approach, combining material synthesis and device fabrication/evaluation, will not only lead to improvements in the performance and stability of OPVs and TFTs but will also give deep insights into how the crystalline packing—independent from the molecular structure—affects the optoelectronic properties. The success of CEMOS will rapidly advance the performance of MOS devices by enabling reproducible and tuneable performance comparable to traditional semiconductors—but at radically lower processing costs."
Summary
"The urgent need to develop inexpensive and ubiquitous solar energy conversion cannot be overstated. Solution processed organic semiconductors can enable this goal as they support drastically less expensive fabrication techniques compared to traditional semiconductors. Molecular organic semiconductors (MOSs) offer many advantages to their more-common pi-conjugated polymer counterparts, however a clear and fundamental challenge to enable the goal of high performance solution-processable molecular organic semiconductor devices is to develop the ability to control the crystal packing, crystalline domain size, and mixing ability (for multicomponent blends) in the thin-film device geometry. The CEMOS project will accomplish this by pioneering innovative methods of “bottom-up” crystal engineering for organic semiconductors. We will employ specifically tailored molecules designed to leverage both thermodynamic and kinetic aspects of molecular organic semiconductor systems to direct and control crystalline packing, promote crystallite nucleation, compatibilize disparate phases, and plasticize inelastic materials. We will demonstrate that our new classes of materials can enable the tuning of the charge carrier transport and morphology in MOS thin films, and we will evaluate their performance in actual thin-film transistor (TFT) and organic photovoltaic (OPV) devices. Our highly interdisciplinary approach, combining material synthesis and device fabrication/evaluation, will not only lead to improvements in the performance and stability of OPVs and TFTs but will also give deep insights into how the crystalline packing—independent from the molecular structure—affects the optoelectronic properties. The success of CEMOS will rapidly advance the performance of MOS devices by enabling reproducible and tuneable performance comparable to traditional semiconductors—but at radically lower processing costs."
Max ERC Funding
1 477 472 €
Duration
Start date: 2014-01-01, End date: 2018-12-31
Project acronym CHAI
Project Cardiovascular Health effects of Air pollution in Andhra Pradesh, India
Researcher (PI) Cathryn Tonne
Host Institution (HI) FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA
Call Details Starting Grant (StG), LS7, ERC-2013-StG
Summary While there is convincing evidence that exposure to particulate air pollution causes cardiovascular mortality and morbidity, nearly all of this evidence is based on populations in high-income countries where concentrations are relatively low. There is large uncertainty regarding the relationship between combustion particles and cardiovascular risk for concentrations higher than outdoor concentrations in urban areas of high-income countries and lower than active smoking. Exposures for our study population are likely to be in this range.
We will investigate the cardiovascular health effects of exposure to particles from outdoor and household sources within a prospective cohort in Andhra Pradesh, India. Firstly, we will characterise exposure of participants using an integrated approach utilising outdoor mobile monitoring, personal monitoring, and questionnaire data. We will then collect data on participants’ activities and location using ‘life-logging’ from which activities driving exposure can be identified. Finally, we will quantify the association between exposure to particles and biomarkers of atherosclerosis.
This research will shed light on the relationship between particles and cardiovascular risk at concentration ranges where there is the largest uncertainty. It will provide some of the first evidence of the cardiovascular health effects of medium-term exposure to particulate air pollution outside of a high-income country. The research will also provide evidence regarding the relative contribution of sources and activities linked to high exposure, forming the basis of recommendations for exposure reduction.
Summary
While there is convincing evidence that exposure to particulate air pollution causes cardiovascular mortality and morbidity, nearly all of this evidence is based on populations in high-income countries where concentrations are relatively low. There is large uncertainty regarding the relationship between combustion particles and cardiovascular risk for concentrations higher than outdoor concentrations in urban areas of high-income countries and lower than active smoking. Exposures for our study population are likely to be in this range.
We will investigate the cardiovascular health effects of exposure to particles from outdoor and household sources within a prospective cohort in Andhra Pradesh, India. Firstly, we will characterise exposure of participants using an integrated approach utilising outdoor mobile monitoring, personal monitoring, and questionnaire data. We will then collect data on participants’ activities and location using ‘life-logging’ from which activities driving exposure can be identified. Finally, we will quantify the association between exposure to particles and biomarkers of atherosclerosis.
This research will shed light on the relationship between particles and cardiovascular risk at concentration ranges where there is the largest uncertainty. It will provide some of the first evidence of the cardiovascular health effects of medium-term exposure to particulate air pollution outside of a high-income country. The research will also provide evidence regarding the relative contribution of sources and activities linked to high exposure, forming the basis of recommendations for exposure reduction.
Max ERC Funding
1 200 000 €
Duration
Start date: 2015-01-01, End date: 2018-12-31
Project acronym COMFUS
Project Computational Methods for Fusion Technology
Researcher (PI) Santiago Ignacio Badia Rodríguez
Host Institution (HI) CENTRE INTERNACIONAL DE METODES NUMERICS EN ENGINYERIA
Call Details Starting Grant (StG), PE8, ERC-2010-StG_20091028
Summary The simulation of multidisciplinary applications use very often a combination of heterogeneous and disjoint numerical techniques that are hard to put together by the user, and whose mathematical foundation is obscure. An example of this situation is the numerical modeling of the physical processes taking place in nuclear fusion reactors. This problem, which can be modeled by a set of partial differential equations, is extremely challenging. It involves (essentially) fluid mechanics, electromagnetics, thermal radiation and neutronics. The most common numerical approaches to each of these problems separately are very different and their coupling is a hard and inefficient task.
Our main objective in this proposal is to develop and analyze a unified numerical framework based on stabilized finite element methods based on multi-scale decompositions capable to simulate all the physical processes taking place in nuclear fusion technology. The project aims at giving a substantial contribution to the numerical approximation of every physical process as well as efficient coupling techniques for the multiphysics problems.
The development of the numerical formulations we propose and their application require mastering different physics, designing numerical approximations for these different physical problems, analyzing mathematically the resulting methods, implementing them in an efficient way in parallel platforms and understanding the results and drawing conclusions, both from a physical and from an engineering perspective. Advanced research in physical modeling, numerical approximations, mathematical analysis and computer implementation are the keys to meeting these objectives.
The successful implementation of the project will provide advanced numerical techniques for the simulation of the processes taking place in a fusion reactor. A deliverable product of the project will be a unified finite element software package that will be an extremely valuable tool.
Summary
The simulation of multidisciplinary applications use very often a combination of heterogeneous and disjoint numerical techniques that are hard to put together by the user, and whose mathematical foundation is obscure. An example of this situation is the numerical modeling of the physical processes taking place in nuclear fusion reactors. This problem, which can be modeled by a set of partial differential equations, is extremely challenging. It involves (essentially) fluid mechanics, electromagnetics, thermal radiation and neutronics. The most common numerical approaches to each of these problems separately are very different and their coupling is a hard and inefficient task.
Our main objective in this proposal is to develop and analyze a unified numerical framework based on stabilized finite element methods based on multi-scale decompositions capable to simulate all the physical processes taking place in nuclear fusion technology. The project aims at giving a substantial contribution to the numerical approximation of every physical process as well as efficient coupling techniques for the multiphysics problems.
The development of the numerical formulations we propose and their application require mastering different physics, designing numerical approximations for these different physical problems, analyzing mathematically the resulting methods, implementing them in an efficient way in parallel platforms and understanding the results and drawing conclusions, both from a physical and from an engineering perspective. Advanced research in physical modeling, numerical approximations, mathematical analysis and computer implementation are the keys to meeting these objectives.
The successful implementation of the project will provide advanced numerical techniques for the simulation of the processes taking place in a fusion reactor. A deliverable product of the project will be a unified finite element software package that will be an extremely valuable tool.
Max ERC Funding
1 320 000 €
Duration
Start date: 2011-01-01, End date: 2015-12-31
Project acronym DAMOC
Project Diabetes Approach by Multi-Organ-on-a-Chip
Researcher (PI) Javier RAMON
Host Institution (HI) FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
Call Details Starting Grant (StG), PE8, ERC-2016-STG
Summary Insulin secretion and insulin action are critical for normal glucose homeostasis. Defects in both of these processes lead to type 2 diabetes (T2D). Unravelling the mechanisms that lead to T2D is fundamental in the search of new molecular drugs to prevent and control this disease. Organ-on-a-chip devices offer new approaches for T2D disease modelling and drug discovery by providing biologically relevant models of tissues and organs in vitro integrated with biosensors. As such, organ-on-a-chip devices have the potential to revolutionize the pharmaceutical industry by enabling reliable and high predictive in vitro testing of drug candidates. The capability to miniaturize biosensor systems and advanced tissue fabrication procedures have enabled researchers to create multiple tissues on a chip with a high degree of control over experimental variables for high-content screening applications. The goal of this project is the fabrication of a biomimetic multi organ-on-a-chip integrated device composed of skeletal muscle and pancreatic islets for studying metabolism glucose diseases and for drug screening applications. Engineered muscle tissues and pancreatic islets are integrated with the technology to detect the glucose consumption, contraction induced glucose metabolism, insulin secretion and protein biomarker secretion of cells. We aim to design a novel therapeutic tool to test drugs with a multi organ-on-a-chip device. Such finding would improve drug test approaches and would provide for new therapies to prevent the loss of beta cell mass associated with T2D and defects in the glucose uptake in skeletal muscle.
Summary
Insulin secretion and insulin action are critical for normal glucose homeostasis. Defects in both of these processes lead to type 2 diabetes (T2D). Unravelling the mechanisms that lead to T2D is fundamental in the search of new molecular drugs to prevent and control this disease. Organ-on-a-chip devices offer new approaches for T2D disease modelling and drug discovery by providing biologically relevant models of tissues and organs in vitro integrated with biosensors. As such, organ-on-a-chip devices have the potential to revolutionize the pharmaceutical industry by enabling reliable and high predictive in vitro testing of drug candidates. The capability to miniaturize biosensor systems and advanced tissue fabrication procedures have enabled researchers to create multiple tissues on a chip with a high degree of control over experimental variables for high-content screening applications. The goal of this project is the fabrication of a biomimetic multi organ-on-a-chip integrated device composed of skeletal muscle and pancreatic islets for studying metabolism glucose diseases and for drug screening applications. Engineered muscle tissues and pancreatic islets are integrated with the technology to detect the glucose consumption, contraction induced glucose metabolism, insulin secretion and protein biomarker secretion of cells. We aim to design a novel therapeutic tool to test drugs with a multi organ-on-a-chip device. Such finding would improve drug test approaches and would provide for new therapies to prevent the loss of beta cell mass associated with T2D and defects in the glucose uptake in skeletal muscle.
Max ERC Funding
1 499 554 €
Duration
Start date: 2017-01-01, End date: 2021-12-31